Koninklijke Philips EBIT 2010-2024 | PHG

Koninklijke Philips annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Koninklijke Philips EBIT for the quarter ending September 30, 2024 was $0.372B, a 3074.72% increase year-over-year.
  • Koninklijke Philips EBIT for the twelve months ending September 30, 2024 was $0.867B, a 14.26% increase year-over-year.
  • Koninklijke Philips 2024 annual EBIT was $0.572B, a 559.92% decline from 2023.
  • Koninklijke Philips 2023 annual EBIT was $-0.124B, a 92.27% decline from 2022.
  • Koninklijke Philips 2022 annual EBIT was $-1.61B, a 346.07% decline from 2021.
Koninklijke Philips Annual EBIT
(Millions of US $)
2024 $572
2023 $-124
2022 $-1,610
2021 $654
2020 $1,761
2019 $1,842
2018 $2,029
2017 $1,715
2016 $2,083
2015 $1,102
2014 $646
2013 $2,645
2012 $1,325
2011 $1,443
2010 $2,641
2009 $774
Koninklijke Philips Quarterly EBIT
(Millions of US $)
2024-09-30 $372
2024-06-30 $879
2023-06-30 $242
2023-03-31 $-626
2022-06-30 $12
2021-06-30 $102
2020-06-30 $252
2019-06-30 $392
2018-06-30 $355
2017-06-30 $278
2016-12-31 $902
2016-09-30 $537
2016-06-30 $425
2016-03-31 $220
2015-12-31 $178
2015-09-30 $381
2015-06-30 $386
2015-03-31 $157
2014-12-31 $2
2014-09-30 $-121
2014-06-30 $455
2014-03-31 $310
2013-12-31 $962
2013-09-30 $615
2013-06-30 $665
2013-03-31 $403
2012-12-31 $95
2012-09-30 $745
2012-06-30 $206
2012-03-31 $586
2011-12-31 $-38
2011-09-30 $200
2011-06-30 $334
2011-03-31 $831
2010-12-31 $986
2010-09-30 $632
2010-06-30 $516
2010-03-31 $525
2009-12-31 $2,266
2009-09-30 $407
2009-06-30 $-1,070
2009-03-31 $-254
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.874B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00